We are live on ! Find out more
KCM

Knoll Capital Management Portfolio holdings

AUM $180M
1-Year Est. Return 66.11%
This Fund
S&P 500
This Quarter Est. Return
+4.95%
1 Year Est. Return
+66.11%
3 Year Est. Return
+268.55%
5 Year Est. Return
+741%
10 Year Est. Return
+10,877.35%
AUM
$141M
AUM Growth
-$13.1M
Cap. Flow
+$7.45M
Cap. Flow %
5.29%
Top 10 Hldgs %
66.07%
Holding
39
New
3
Increased
3
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
CGAU
Centerra Gold
CGAU
+$8.4M
2
OBIO icon
Orchestra BioMed
OBIO
+$1.33M
3
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$909K
4
ABEO icon
Abeona Therapeutics
ABEO
+$357K
5
RGLD icon
Royal Gold
RGLD
+$257K

Top Sells

Rank Stock Value
1
EQX icon
Equinox Gold
EQX
+$3.79M
2
SKE
Skeena Resources
SKE
+$252K

Sector Composition

Rank Sector Weight
1 Healthcare 54.97%
2 Materials 30.41%
3 Consumer Staples 1.78%
4 Industrials 1.73%
5 Financials 1.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALDX icon
1
Aldeyra Therapeutics
ALDX
$91.7M
$21M 14.91%
5,475,516
– –
BHVN
2
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$12.6M 8.98%
895,269
+64,390
+8% +$909K
ENTX icon
3
Entera Bio
ENTX
$101M
$11.2M 7.95%
5,881,879
– –
GLD icon
4
SPDR Gold Trust
GLD
$131B
$9.75M 6.94%
32,000
– –
MGTX icon
5
MeiraGTx Holdings
MGTX
$1.09B
$8.15M 5.79%
1,250,000
– –
KGC icon
6
Kinross Gold
KGC
$28.5B
$6.88M 4.89%
440,000
– –
AEM icon
7
Agnico Eagle Mines
AEM
$72.6B
$6.6M 4.69%
55,500
– –
SAND
8
DELISTED
Sandstorm Gold
SAND
$6.58M 4.68%
700,000
– –
AVDL
9
DELISTED
Avadel Pharmaceuticals
AVDL
$5.31M 3.78%
600,000
– –
ELTX icon
10
Elicio Therapeutics
ELTX
$78.8M
$4.87M 3.46%
630,915
– –
SKE
11
Skeena Resources
SKE
$3.36B
$4.7M 3.34%
295,400
-20,000
-6% -$252K
SA
12
Seabridge Gold
SA
$2.8B
$4.6M 3.27%
317,003
– –
ALT icon
13
Altimmune
ALT
$539M
$4.34M 3.09%
1,121,524
– –
FNV icon
14
Franco-Nevada
FNV
$41.4B
$4.1M 2.91%
25,000
– –
MAG
15
DELISTED
MAG Silver
MAG
$3.59M 2.55%
170,000
– –
NUVB icon
16
Nuvation Bio
NUVB
$2.24B
$2.92M 2.08%
1,025,000
– –
SLV icon
17
iShares Silver Trust
SLV
$28.1B
$2.62M 1.87%
80,000
– –
APLT
18
DELISTED
Applied Therapeutics
APLT
$2.43M 1.72%
7,799,687
– –
OCUL icon
19
Ocular Therapeutix
OCUL
$1.86B
$1.86M 1.32%
600,400
– –
PM icon
20
Philip Morris
PM
$301B
$1.82M 1.29%
10,000
– –
V icon
21
Visa
V
$677B
$1.72M 1.22%
4,850
– –
RGLD icon
22
Royal Gold
RGLD
$17.1B
$1.6M 1.14%
9,000
+1,450
+19% +$257K
ITA icon
23
iShares US Aerospace & Defense ETF
ITA
$14.2B
$1.44M 1.03%
7,650
– –
BAH icon
24
Booz Allen Hamilton
BAH
$8.7B
$1.35M 0.96%
13,000
– –
AGI icon
25
Alamos Gold
AGI
$12.4B
$1.33M 0.94%
50,000
+9,000
+22% +$241K
1
2

Similar funds

MGWA
Monument Group Wealth Advisors Concord, Massachusetts $180M AUM 19.81% 1-Year Est. Return
AW
Alchemi Wealth Essex, Connecticut $180M AUM
FBC
Fairfield, Bush & Co Darien, Connecticut $180M AUM 39.51% 1-Year Est. Return
AIC
Aurora Investment Counsel Atlanta, Georgia $180M AUM 0.3% 1-Year Est. Return
AG
Amiral Gestion Paris, France $180M AUM 9.43% 1-Year Est. Return
PCA
Prospect Capital Advisors Sausalito, California $180M AUM 60.99% 1-Year Est. Return
HIC
Hamrick Investment Counsel Seattle, Washington $180M AUM
FFA
Frazier Financial Advisors Columbus, Ohio $181M AUM 11.16% 1-Year Est. Return

Knoll Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Knoll Capital Management held 39 positions worth $141M, down 8.5% from $154M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Knoll Capital Management deployed $7.45M of net new capital in Q2 2025, opening 3 new positions and adding to 3 existing holdings. Its largest new stake was Centerra Gold: 1,227,863 shares worth $170K.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, down from 62% a quarter earlier, followed by Materials and Consumer Staples.

On the sell side, the largest reduction was Skeena Resources, an estimated $252K trimmed.

  • Knoll Capital Management's largest Q2 2025 buy was Centerra Gold: 1,227,863 shares worth $170K.
  • Knoll Capital Management added most to Biohaven Pharmaceutical Holding Company Ltd. in Q2 2025, an estimated $909K increase.
  • Knoll Capital Management's biggest Q2 2025 reduction was Skeena Resources, cutting an estimated $252K.
  • Knoll Capital Management fully exited Equinox Gold in Q2 2025, selling an estimated $3.79M.
  • Knoll Capital Management's ten largest holdings make up 66% of its $141M portfolio in Q2 2025.
  • Knoll Capital Management opened 3 new positions and closed 1 in Q2 2025.
  • Knoll Capital Management's portfolio value fell 8.5% quarter-over-quarter to $141M.

Based on Knoll Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.